AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 221 filers reported holding AMICUS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $812,020 | -40.2% | 66,778 | -38.2% | 0.00% | -50.0% |
| Q2 2023 | $1,357,597 | +304.7% | 108,089 | +257.4% | 0.00% | +100.0% |
| Q1 2023 | $335,417 | +1.1% | 30,245 | +11.3% | 0.00% | 0.0% |
| Q4 2022 | $331,818 | +16.0% | 27,176 | -1.1% | 0.00% | 0.0% |
| Q3 2022 | $286,000 | -8.6% | 27,478 | -5.7% | 0.00% | 0.0% |
| Q2 2022 | $313,000 | -79.2% | 29,152 | -81.7% | 0.00% | -50.0% |
| Q1 2022 | $1,505,000 | -17.8% | 158,991 | +0.3% | 0.00% | 0.0% |
| Q4 2021 | $1,831,000 | – | 158,541 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |